Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant. [electronic resource]
- Drug metabolism and personalized therapy 03 2017
- 49-58 p. digital
Publication Type: Journal Article
2363-8915
10.1515/dmpt-2016-0040 doi
ATP Binding Cassette Transporter, Subfamily B--genetics Cytochrome P-450 CYP3A--genetics Diabetes Mellitus--genetics Dyslipidemias--genetics Female Graft Survival--genetics Humans Hypertension--genetics Kidney Transplantation Male Middle Aged Polymorphism, Single Nucleotide--genetics Sirolimus--pharmacokinetics Treatment Outcome